Post Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researchers
Post Tessa Therapeutics, Parker Institute partner to jointly advance research in cancer immunotherapy
Post The sandbox: Parker Institute throws its research muscle behind gene therapy tech for destroying cancer cells
Post Ute Dugan Joins the Parker Institute for Cancer Immunotherapy as Senior Vice President of Clinical Research